Treatment for Adolescents With Depression Study (TADS): Rationale, Design, and Methods
- 1 May 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 42 (5) , 531-542
- https://doi.org/10.1097/01.chi.0000046839.90931.0d
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Emergency/Adjunct Services and Attrition Prevention for Randomized Clinical Trials in Children: The MTA Manual-Based SolutionJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2001
- A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic DepressionNew England Journal of Medicine, 2000
- Psychosocial treatments for adolescent depressionClinical Psychology Review, 1999
- Summary of the Practice Parameters for the Assessment and Treatment of Children and Adolescents With Depressive DisordersJournal of the American Academy of Child & Adolescent Psychiatry, 1998
- Perceived parental burden and service use for child and adolescent psychiatric disorders.American Journal of Public Health, 1998
- Changing Patterns of Psychotropic Medications Prescribed by Child Psychiatrists in the 1990sJournal of Child and Adolescent Psychopharmacology, 1997
- What drives outcomes for emotional and behavioral disorders in children and adolescents?New Directions for Mental Health Services, 1996
- Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III—R disorders in high school students.Journal of Abnormal Psychology, 1993